Case reportPublished 23 Nov 2021
Treatment of Arsenic Toxicity during APML Treatment in a Pediatric Patient
1Department of Pediatric Critical Care, University of Maryland Medical Center, Baltimore, USA; 2Department of Pediatrics, University of Maryland School of Pharmacy, Baltimore, USA; 3Department of Neonatal Critical Care, NewYork-Presbyterian Hospital, New York, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
A 17-year-old healthy female was presented with altered mentation after a fall. The workup revealed a new onset of APML. Chemotherapy was initiated. She developed MODS requiring ECMO and CVVHDF. Two days after discontinuation of support, the patient developed acute worsening mentation, emesis, diarrhea, tachycardia, fever, creatinine of 9.58 mg/dL, and prolonged QTc-582, indicating arsenic poisoning from chemotherapy.
Subjects
ToxicologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalToxicology: Open Access
- SubjectToxicology
- BylineArticles whose byline prints “Ripal Patel”
- BylineArticles whose byline prints “Omayma Kishk”
- BylineArticles whose byline prints “Dimitrios A Savva”
- BylineArticles whose byline prints “Adrian Holloway”